178 related articles for article (PubMed ID: 31094808)
1. Dezocine Alleviates Morphine-Induced Dependence in Rats.
Wu FX; Babazada H; Gao H; Huang XP; Xi CH; Chen CH; Xi J; Yu WF; Liu R
Anesth Analg; 2019 Jun; 128(6):1328-1335. PubMed ID: 31094808
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence.
Ahsan MZ; Zhao MJ; Shoaib RM; Zhang Y; Wang YX
Life Sci; 2021 Nov; 285():119996. PubMed ID: 34597607
[TBL] [Abstract][Full Text] [Related]
3. Novel molecular targets of dezocine and their clinical implications.
Liu R; Huang XP; Yeliseev A; Xi J; Roth BL
Anesthesiology; 2014 Mar; 120(3):714-23. PubMed ID: 24263237
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist.
Wang YH; Chai JR; Xu XJ; Ye RF; Zan GY; Liu GY; Long JD; Ma Y; Huang X; Xiao ZC; Dong H; Wang YJ
Sci Rep; 2018 Sep; 8(1):14087. PubMed ID: 30237513
[TBL] [Abstract][Full Text] [Related]
5. Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain.
Wu LX; Dong YP; Zhu QM; Zhang B; Ai BL; Yan T; Zhang GH; Sun L
BMC Cancer; 2021 Oct; 21(1):1128. PubMed ID: 34670518
[TBL] [Abstract][Full Text] [Related]
6. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
[TBL] [Abstract][Full Text] [Related]
7. Effects of processed Aconiti tuber on the extinction and reinstatement of morphine-induced conditioned place preference in rats.
Wu G; Xu X; Ye F; Shu H
J Ethnopharmacol; 2021 Mar; 267():113524. PubMed ID: 33129945
[TBL] [Abstract][Full Text] [Related]
8. Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibition.
Wang YX; Mao XF; Li TF; Gong N; Zhang MZ
Sci Rep; 2017 Feb; 7():43137. PubMed ID: 28230181
[TBL] [Abstract][Full Text] [Related]
9. Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain.
Mao XF; Ahsan MZ; Apryani E; Tang XQ; Zhao MJ; Li XY; Wang YX
Eur J Pharmacol; 2020 Jun; 876():173062. PubMed ID: 32173379
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats.
Wu G; Huang W; Zhang H; Li Q; Zhou J; Shu H
J Ethnopharmacol; 2011 Jun; 136(1):254-9. PubMed ID: 21549821
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors.
Shang L; Duan C; Chang S; Chang N; Jia S
Behav Pharmacol; 2021 Sep; 32(6):472-478. PubMed ID: 34101632
[TBL] [Abstract][Full Text] [Related]
12. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.
Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB
Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631
[TBL] [Abstract][Full Text] [Related]
13. Dezocine Antagonizes Morphine Analgesia upon Simultaneous Administration in Rodent Models of Acute Nociception.
Li NN; Huang YQ; Huang LE; Guo SH; Shen MR; Guo CL; Zhu SM; Yao YX
Pain Physician; 2017 Mar; 20(3):E401-E409. PubMed ID: 28339439
[TBL] [Abstract][Full Text] [Related]
14. Divergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.
Bian X; Zhou R; Yang Y; Li P; Hang Y; Hu Y; Yang L; Wen D
Int J Med Sci; 2015; 12(11):848-52. PubMed ID: 26640403
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Picker MJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
[TBL] [Abstract][Full Text] [Related]
17. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
[TBL] [Abstract][Full Text] [Related]
18. Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens.
Baharlouei N; Sarihi A; Komaki A; Shahidi S; Haghparast A
Pharmacol Biochem Behav; 2015 Aug; 135():192-8. PubMed ID: 26071679
[TBL] [Abstract][Full Text] [Related]
19. Dezocine for Preventing Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials.
Zhou X; Zhang C; Wang M; Yu L; Yan M
PLoS One; 2015; 10(8):e0136091. PubMed ID: 26287536
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
